Anzeige
Mehr »
Samstag, 20.12.2025 - Börsentäglich über 12.000 News
Jackpot-News! Q-Gold lässt die "goldene Weihnachts-Katze" aus dem Sack
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrIAMGOLD completes acquisition of Northern Superior Resources
FrKeyBanc reiterates Overweight rating on Darden stock amid share gains
FrFuelCell Energy stock holds steady as KeyBanc reiterates Sector Weight
FrCiti stock rating reiterated at Outperform by KBW on improved outlook
FrStifel maintains Buy rating on Elanco Animal Health stock with $27 price target
FrKeyBanc reiterates Overweight rating on Matador Resources stock
FrBKV stock rating reiterated at Overweight by KeyBanc on CCUS potential
FrBernstein reiterates Market Perform rating on Birkenstock stock after mixed results
FrStifel raises Regenxbio stock price target to $45 on upcoming catalysts
FrStifel raises Supernus Pharmaceuticals stock price target to $55 from $50
FrJ. Smart & Co. to hold annual general meeting on January 22
FrSienna Senior Living completes acquisition of 78.2% stake in LaSalle Park
FrARKO Corp files registration for subsidiary IPO
FrEve completes first flight of full-scale eVTOL prototype
FrMirum secures $68.5 million in private placement ahead of acquisition
FrAether Holdings appoints Wayne Huo to board of directors
FrFederal court approves meeting for Snow Lake's GUE acquisition
FrTelos awarded $151 billion IDIQ contract by Missile Defense Agency
FrVisionary Copper completes $3.04 million private placement
FrGlobal Mofy AI closes $4.8 million private placement
FrStifel maintains Hold rating on Cintas stock, keeps $222 price target
FrFedEx stock outperforms in F2Q26 as Oppenheimer maintains Perform rating
FrTilray stock price target raised to $10 from $1 by Bernstein on cannabis rescheduling
FrTrevi Therapeutics stock price target raised to $18 by Stifel on cough drug potential
FrGuggenheim raises Maze Therapeutics stock price target to $46 on CKD program